Secukinumab Market to Grow at a CAGR of 6.8% Through 2032 According to a newly published market research report by 24LifeSciences, global secukinumab market was valued at USD 4.5 billion in 2024 and is projected to reach USD 7.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025–2032. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9981/secukinumab-market